Inhalation challenges with occupational agents: Threshold duration of exposure  by D'Alpaos, Vinciane et al.
Respiratory Medicine (2013) 107, 739e744Available online at www.sciencedirect.com
journal homepage: www.elsevier .com/locate/rmedInhalation challenges with occupational
agents: Threshold duration of exposureVinciane D’Alpaos a, Olivier Vandenplas a,b,*,
Genevie`ve Evrard a, Jacques Jamart caDepartment of Chest Medicine, Centre Hospitalier Universitaire de Mont-Godinne, Universite´
Catholique de Louvain, Yvoir, Belgium
b Fonds des Maladies Professionnelles, Brussels, Belgium
c Scientific Support Unit, Centre Hospitalier Universitaire de Mont-Godinne,
Universite´ Catholique de Louvain, Yvoir, BelgiumReceived 31 October 2012; accepted 12 January 2013
Available online 14 February 2013KEYWORDS
Asthma;
Bronchoprovocation
tests;
Occupational diseasesAbbreviations: FEV1, forced expirator
asthma; PC20, provocative concentrat
duration of exposure inducing a 20%
* Corresponding author. Department
Yvoir, Belgium. Tel.: þ32 81 42 33 63.
E-mail address: olivier.vandenplas
0954-6111/$ - see front matter ª 201
http://dx.doi.org/10.1016/j.rmed.201Summary
Objectives: The aim of this study was to characterize the threshold duration of exposure
needed to elicit an asthmatic reaction during specific inhalation challenges (SIC) with various
occupational agents and to determine the duration of exposure that should be completed be-
fore the test can be considered negative.
Methods: This retrospective study analysed the cumulative duration of challenge exposure
that was required to elicit a 20% fall in forced expiratory volume in one second in 335 con-
secutive subjects with a positive SIC.
Results: The threshold duration of challenge exposure required to induce an asthmatic reac-
tion was 60 min in 179 (53%) subjects, between 61 and 120 min in 74 (22%) subjects, and long-
er than 120 min in 82 (25%) subjects. The multivariate linear regression analysis showed that
a longer duration of exposure was associated with exposure to low-molecular-weight agents
(p < 0.001), a higher level of baseline non-specific bronchial hyperresponsiveness to histamine
(p Z 0.015), increasing age (p Z 0.011), and a shorter duration of asthma symptoms at work
(p Z 0.060).
Conclusions: This study demonstrates that the sensitivity of SICs for diagnosing OA is highly de-
pendent upon the duration of the challenge exposure. These data may provide useful guidance
for improving the reliability of SICs performed with realistic methods of exposure.
ª 2013 Elsevier Ltd. All rights reserved.y volume in one second; HMW, high molecular weight; LMW, low molecular weight; OA, occupational
ion of histamine causing a 20% fall in FEV1; SIC, specific inhalation challenge; TD20%FEV1, threshold
fall in FEV1.
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cubic-meter cubicles using a realistic approach.10,12 AsthmaA specific inhalation challenge (SIC) with occupational
agents is still regarded as the “reference” method to
establish the diagnosis and aetiology of immunologically-
mediated occupational asthma (OA).1e3 A major limitation
of SICs is their potential for inducing false-negative results
when specific bronchial reactivity to the sensitizing agent
has declined after cessation of workplace exposure.4e9
Using a closed-circuit device that allows for generating
quantified levels of various agents, Lemie`re and co-workers
elegantly demonstrated that the specific bronchial reac-
tivity to sensitizing occupational agents almost never
completely disappear after cessation of exposure,8,9
although the dose of the agent required for inducing
a positive SIC response significantly increases.8
Since standardized preparations are not available for
most occupational agents, SICs are still usually performed
by exposing the subjects to the suspected occupational
agent using the “realistic” approach originally described by
Pepys and Hutchcroft in the early 1970s.10 This methodol-
ogy aims at reproducing as close as possible the conditions
of exposure at the workplace in terms of the chemical and
physical characteristics of the agent, for example, dust,
aerosol, vapour, or fume.10e13 The concentrations of the
agents generated during these SICs are usually not meas-
ured due to the wide diversity of the tested agents and the
high technical demands for controlling exposures. In these
realistic SICs, the duration of the challenge exposure is
used as a surrogate of the dose of the agent delivered to
the subjects. However, the cumulative duration of expo-
sure to the suspected agent, which should be completed
before the test can be considered negative, has never been
thoroughly evaluated.
The aim of this study was to characterize the threshold
duration of exposure that was required to elicit a 20% fall
in FEV1 (TD20%FEV1) in a large series of positive SICs induced
by various occupational agents as well as to identify the
factors that can affect this parameter.
Methods
Study design and population
In this retrospective study, the records of all subjects
investigated for possible OA who showed a positive SIC,
defined by a 20% fall in FEV1, from January 1992 to
December 2011 at our institution were reviewed. These
tests are routinely performed in our centre in the inves-
tigation of work-related asthma. The protocol of the study
was approved by the Comite´ d’e´thique me´dicale du Centre
Hopitalier Universitaire de Mont-Godinne (approval num-
ber 84-2012). A statement of informed consent was not
required because the data were analysed retrospectively in
an anonymous way.
Specific inhalation challenges
SICs were completed according to a previously described
protocol12,14,15 that remained unchanged over the reviewedperiod. Briefly, occupational agents were generated in five-
medications were withdrawn according to their duration of
action,11 while inhaled corticosteroids were halted 72 h
prior to the tests. The level of exposure during SICs was
continuously monitored only for isocyanates using an MDA
7100 monitor (MDA Scientific Inc., Glenview, IL) and was
kept below the ceiling value of 20 ppb.
Spirometry16,17 was obtained at baseline, immediately
after each exposure, then every 15 min for the first hour,
every 30 min for the second hour, and hourly thereafter for
a total of at least six hours after the end of exposure. The
baseline level of non-specific bronchial hyper-
responsiveness to histamine14 and, since 2006, sputum
eosinophil counts15 were assessed at the end of the control
day and re-assessed 6 and 24 h after the active challenges.
The degree of non-specific bronchial hyperresponsiveness
was expressed as the provocative concentration of hista-
mine causing a 20% fall in FEV1 (PC20).
18 A SIC was consid-
ered positive when a sustained 20% fall in FEV1 was
recorded on two consecutive assessments. The pattern of
bronchial responses was characterized as immediate, late,
dual, or atypical according to previously described
criteria.10,19
On the first day, the subjects were exposed to a ‘control’
agent for 30 min to ensure that FEV1 fluctuations were
12% of the baseline value. The ‘control’ substance was
selected according to the nature of the occupational agent
suspected of causing OA. For instance, lactose powder was
used as the ‘control’ substance for SIC with agents in
powder form (e.g. flour, drugs, persulphates), pine dust for
SIC with wood dusts, vinyl gloves for SIC with latex gloves,
and diluents for polyurethane products and other resins. On
the following day, the subjects were challenged with the
suspected occupational agent (s). The duration of exposure
to both high-molecular-weight (HMW) and low-molecular-
weight (LMW) agents was gradually increased (i.e. 1 min,
4 min, 10 min, 15 min, 30 min, and 60 min) until a 20% fall
in FEV1 occurred or a cumulative exposure of two hours was
completed. Those subjects who did not demonstrate
a 20% fall in FEV1 during the first active test day under-
went a repeated challenge in the same way for a maximum
of 2e3 h on the next day. Accordingly, all subjects were
challenged for at least 240 min before considering the SIC
as being negative. In addition, further challenges were
proposed when there was a significant (>3-fold) decrease in
the post-challenge PC20 value
14 or an increase in sputum
eosinophils >3%,15 as compared to the control day values.Data analysis
Quantitative data are presented as median with 25th and
75th percentiles. Comparison between subgroups of sub-
jects was made using the Chi-square test for categorical
variables and the Wilcoxon rank-sum test for numerical
variables. A multivariate linear regression analysis was
conducted to identify the factors that affected the TD20%
FEV1. The independent variables incorporated into the
regression model included the relevant demographic and
clinical characteristics of the subjects (i.e. age, gender,
and smoking status, atopy, duration of asthma symptoms at
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and SIC), indices reflecting asthma severity (dose of inhaled
corticosteroids needed to control asthma, FEV1 % pre-
dicted, FEV1/forced vital capacity ratio, and baseline his-
tamine PC20 value), and the category of the tested agent
(i.e. HMW vs. LMW agent). The regression analysis was
performed using a backward selection by Wald test. All
statistical tests are two-tailed. A p-value <0.05 was con-
sidered significant. Statistical analysis was performed using
the IBM SPSS Statistics 19.0 software (SPSS Inc, Chicago, Ill).Results
During the period from 1992 to 2011, a total of 335 subjects
showed a positive SIC in terms of the changes in FEV1. The
main demographic and clinical characteristics of the sub-
jects are summarized in Table 1. The agents having caused
a positive SIC were HMW agents in 206 (61%) subjects andTable 1 Demographic and clinical characteristics of the subjec
All patients
with positive
SIC (n Z 335)
Gender (male) 204 (61)
Age, yra 37 (31e46)
Current and ex-smokers 129 (39)
Atopyb 204 (61)
Duration of asthma before SIC, moa 30 (13e65)
Delay since last work exposure, moa 3 (0.1e14)
Inhaled corticosteroidc
Low dose 31 (9)
Medium dose 73 (22)
High dose 48 (14)
Baseline FEV1,% pred
a 92 (81e101)
Baseline FEV1 <80% pred 72 (21)
Baseline FEV1/FVC, %
a 75 (69e80)
Baseline FEV1/FVC <70% 87 (26)
Baseline histamine PC20, mg/mL
a 1.75 (0.43e5.50)
>16 mg/ml 39 (12)
>2e16 mg/ml 108 (32)
>0.25e2 mg/ml 123 (37)
0.25 mg/ml 65 (19)
Type of occupational agents
Low molecular weight 123 (37)
High molecular weight 206 (61)
Indeterminate 6 (2)
Pattern of asthmatic reaction
Immediate 187 (56)
Dual 60 (18)
Isolated late 19 (6)
Atypical prolonged immediate 61 (18)
Atypical progressive 8 (2)
Data are presented as n (% of available data) unless otherwise specified
capacity; PC20: provocative concentration of histamine causing a 2
specific inhalation challenge.
a Median value with 25the75th percentiles in parentheses.
b Atopy defined by the presence of a positive skin-prick test to at l
c Daily dose of inhaled corticosteroid expressed as beclomethasone
day; medium dose: more than 500 mg but equal or less than 1000 mgLMW agents in 123 (37%) instances, while the causal agent
remained indeterminate in six cases. Among the HMW
substances, latex was the main causative agent (n Z 91,
27%), followed by flour (n Z 89, 27%), and enzymes
(nZ 14, 4%). The principal LMW causal agents were metals
(nZ 24, 7%), isocyanates (nZ 23, 7%), wood dusts (nZ 21,
6%), quaternary ammonium compounds (n Z 10, 3%), and
persulfate salts (n Z 8, 2%).
The distribution of TD20%FEV1 values is presented in Table
2. Noticeably, 82 of the 335 (25%) subjects required
a challenge exposure of more than two hours (Table 1).
These subjects were slightly older (40 [25the75th percen-
tile: 32e49] yr vs. 36 [25the75th percentile: 31e44] yr,
pZ 0.038), were more often current or ex-smokers (49% vs.
35%, pZ 0.028), showed less often an atopic status (50% vs.
64%, p Z 0.020), and had a higher histamine PC20 value
(3.20 [0.94e4.84] mg/ml vs. 1.36 [0.35e4.16] mg/ml,
p Z 0.001) as compared to the other subjects. The SICs
with LMW agents required more frequently (39 of 123ts.
Duration of SIC
exposure
120 min (n Z 253)
Duration of SIC
exposure
>120 min (n Z 82)
p-Value
150 (59) 54 (66) 0.290
36 (31e44) 40 (32e49) 0.038
89 (35) 40 (49) 0.028
163 (64) 41 (50) 0.020
32 (14e67) 28 (13e54) 0.210
3 (0.1e15) 1.8 (0.1e14) 0.619
24 (9) 7 (9) 0.707
58 (23) 15 (18)
33 (13) 15 (18)
92 (80e100) 92 (82e102) 0.370
58 (23) 14 (17) 0.262
75 (69e80) 76 (69e81) 0.255
66 (26) 21 (26) 0.932
1.36 (0.35e4.16) 3.20 (0.94e4.84) 0.001
25 (10) 14 (17) 0.005
75 (30) 33 (40)
99 (39) 24 (29)
54 (21) 11 (13)
84 (33) 39 (48) 0.015
166 (66) 40 (49)
3 (1) 3 (4)
134 (53) 53 (65) 0.005
54 (21) 6 (7)
10 (4) 9 (11)
48 (19) 13 (16)
7 (3) 1 (1)
. FEV1: forced expiratory volume in one-second; FVC: forced vital
0% fall in FEV1; SABA: (inhaled) short-acting beta2-agonist; SIC:
east one common inhalant allergen.
dipropionate equivalent; low dose: equal or less than 500 mg per
per day; and high dose: more than 1000 mg per day.
Table 2 Duration of challenge exposure required to induce an asthmatic reaction.
Cumulative duration of exposure
to occupational agents inducing
a 20% fall in FEV1
Number (%) of SICs
All agents (n Z 335) HMW agents
(n Z 204)
LMW agents
(n Z 126)
5 min 61 (18) 49 (24) 12 (10)
6e15 min 39 (12) 33 (16) 5 (4)
16e30 min 38 (11) 24 (12) 14 (11)
31e60 min 41 (12) 24 (12) 17 (13)
61e120 min 74 (22) 34 (17) 38 (30)
121e240 min 62 (19) 31 (15) 29 (23)
>240 min 20 (6) 9 (4) 11 (9)
HMW: High-molecular weight; LMW: Low-molecular-weight; SIC: Specific inhalation challenges.
742 V. D’Alpaos et al.[31.7%] SICs) an exposure longer than two hours than those
performed with HMW agents (40 of 206 [19.4%] SICs,
pZ 0.015). TD20%FEV1 was more frequently 120 min in dual
reactions and >120 min in isolated late reactions (Table 1).
The multivariate linear regression analysis showed that
a longer threshold duration of exposure was associated with
LMW agents (beta coefficient [SE]: 44.09 [10.06],
p < 0.001), a higher baseline histamine PC20 value (1.18
[0.53], pZ 0.028), increasing age (1.44 [0.56], pZ 0.010),
and a shorter duration of asthma symptoms at work (0.15
[0.79], p Z 0.062).Discussion
This study showed that a substantial proportion of subjects
who completed an SIC procedure using a “realistic” meth-
odology required a prolonged exposure to the causal
occupational agent for developing an asthmatic reaction.
Namely, the TD20%FEV1 was longer than one hour in 47% of
the subjects and longer than two hours in 25%. These data
demonstrate that the sensitivity of SICs for diagnosing OA
may be highly dependent upon the duration of challenge
exposure.
It has been shown that the total dose of the agent e
rather than either the concentration or duration of expo-
sure e determines the bronchial response to LMW and HMW
occupational agents in an individual subject with OA.20,21 In
this study, the duration of exposure to the occupational
agents was used as a rough estimate of the dose that was
delivered to the subjects. The data reflect a “real-life”
setting, wherein the concentrations of agents generated
through the realistic methods are highly variable and can-
not be easily controlled.22,23 Indeed, determining the con-
centrations of various LMW chemicals requires appropriate
equipment that is not easily available and that most often
provide an a posteriori estimate of the mean concentration
to which the subject has been exposed during the SIC. In
our centre, instantaneous concentrations were assessed
only for isocyanates, which can induce severe asthmatic
reactions at very low levels. On the other hand, water-
soluble HMW agents24,25 and some LMW agents (e.g. plati-
num salts,7 reactive dyes,26 and persulfate salts27) can be
administered through the nebulization of increasing con-
centrations of the agent diluted in saline. However,standardized and validated extracts of occupational agents
are lacking for most occupational agents.28 Closed-circuit
devices that make it possible to deliver known and stable
concentrations of occupational agents in various forms have
been developed,23,29,30 but these apparatuses are expen-
sive and require a pre-calibration process for each tested
agent.31 Even with such sophisticated devices, measuring
the levels of airborne particles during the SIC does not
accurately reflect the actual dose of allergens inhaled by
the subjects.
Our retrospective data were used to investigate the host
factors that could help in identifying the subjects who need
a long duration of exposure in order to induce an asthmatic
reaction. The multivariate linear regression analysis
revealed that a low level of baseline non-specific bronchial
hyperresponsiveness (i.e. a high histamine PC20 value)
appeared as the principal determinant of a longer TD20%FEV1.
The dose of non-occupational inhalant allergens required to
induce an asthmatic reaction is dependent upon both the
level of non-specific bronchial hyperresponsiveness and the
degree of immunological reactivity to the allergen, as
assessed either by the skin end-point or the level of specific
IgE antibodies.32,33 There are only scarce data pertaining to
occupational agents. With regards to HMW and LMW occu-
pational agents, the level of specific bronchial reactivity has
been inconsistently related to the degree of non-specific
bronchial hyperresponsiveness.9,30,34,35 For HMW agents,
the main determinant of the specific bronchial reactivity
seemed to be the level of specific IgE sensitization,9,35
which was not taken into account in our analysis because
of the diversity of the tested HMW agents. The multivariate
analysis also suggested that the duration of exposure
required for eliciting a positive FEV1 response increased
with increasing age and decreasing duration of work-related
asthma symptoms. The latter finding may suggest that
subjects with a shorter duration of OA require a higher dose
of the sensitizing agent to induce an asthmatic response.
A high proportion of the subjects had been removed
from workplace exposure for a long time before referral for
an SIC procedure. However, the median delay since last
work exposure was three months, which is similar to the
figure reported by Malo and co-workers (i.e. 76 days) in
a large series of subjects investigated for possible OA.36
Disconcertingly, the interval of time elapsed since the last
work exposure did not affect directly the TD20%FEV1. Several
Duration of challenge exposure to occupational agents 743studies that involved re-challenging subjects with OA at
variable intervals after the initial SIC documented that the
specific bronchial reactivity to occupational agents may
decrease after cessation of the sensitizing agent,4e6,8 with
the exception of a study involving platinum salts [Merget,
1994 #477}. Using the same concentrations of the agents as
those generated during the initial SIC, Lemie`re and co-
workers found that the duration of exposure, and con-
sequently the total dose, required for inducing a positive
SIC response significantly increased (w3-fold on average) in
subjects with OA due to various agents who were re-
challenged two years after removal from exposure.8 How-
ever, in a similar study conducted in subjects with OA
caused by HMW agents who had been removed form expo-
sure for a longer interval (on average 5.7 yr) and who had
normalized their non-specific hyperresponsiveness to
methacholine, the dose needed to elicit a bronchial
response was not modified at the follow-up assessment.9
The multivariate linear regression analysis also revealed
that LMW agents more frequently required a longer TD20%
FEV1 than HMW agents. This retrospective study does not
allow for determining whether this finding was related to
differences in the mode of exposure or in the intrinsic
‘asthmagenic’ properties between these two categories of
agents, which act through presumably different immuno-
logic mechanisms.37 Nevertheless, differences in the levels
of exposure did not appear to account for the observed
difference, since the proportion of subjects with a TD20%
FEV1 of more than two hours still remain significantly higher
for LMW agents (45%) as compared to HMW agents (29%,
p Z 0.025) after exclusion of SICs with isocyanates, whose
concentrations were continuously measured and kept
below the permissible levels (data not detailed). It has
been shown that LMW agents induce more frequently iso-
lated late asthmatic reactions than HMW agents.19,38,39
According to our protocol, challenge exposures are dis-
continued as soon as an early reaction occurs, while late
reactions develop only after the end of the 2-h challenge
exposure, which may contribute to the longer duration of
exposure observed in SIC with LMW agents.
Altogether, the findings of this retrospective study pro-
vide some evidence that the duration of exposure may be
regarded as a useful, though very crude, parameter for
guiding the exposure during realistic SICs. However, since
the concentrations of the tested occupational agents were
not known with the exception of isocyanates, our study
aimed only at providing practical guidance for performing
SIC with “realistic” methods of exposure, and our findings
cannot be directly applied to other challenge procedures.
An accurate identification of the respective role of the host
and exposure factors that determine the specific bronchial
reactivity to occupational agents would require further in-
vestigations with a precise quantification of the level of
exposure during SIC.23,29,30
Despite its inherent limitations, this study has practical
implications in the investigation of OA through SIC using
realistic methods of exposure to occupational agents. The
data indicate that an SIC involving a short period of expo-
sure to the suspected occupational agent (usually
30e60 min) may not be sensitive enough for accurately
excluding the diagnosis of OA. This finding further empha-
size the need for using markers of the bronchial response tooccupational agents that are more sensitive than the
assessment of airway calibre, such as the changes in the
post-challenge level of non-specific bronchial responsive-
ness to histamine/methacoline14,40 and in sputum eosino-
phil counts15,41. Alternatively, the sensitivity of SICs for
diagnosing OA can be markedly improved by increasing the
duration of exposure.Funding
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